sellmefear
← all entries

ONE SOURCE, MANY MASTHEADSMonday 17 August 2026

5 outlets carried this. They resolve to 1 independent source.

A reader sampling these outlets received 1 account, not 5.

As published

5 pages captured at the time, in each outlet's own typography. Open one to read the copy held outside the publisher's control.

5outlets→1independent
What happened, for context

Zeus Hygia Lifesciences announced publication of a clinical study on Metaberine®, a bio-optimised berberine formulation, in the International Journal of Clinical Trials. The randomized, double-blind, placebo-controlled crossover trial of 36 healthy adults found that 200 mg daily dosing significantly improved markers of metabolic health including fasting glucose, GLP-1 response, and lipid parameters, with no adverse events reported.

4 of 5 articles were readable. Headline only, no body text retrieved, for: asiafoodjournal.com. Nothing below is drawn from those outlets beyond their headline.

Who reported it

    • asiafoodjournal.comUNCLASSIFIED
    • business-standard.comUNCLASSIFIED
    • theprint.inUNCLASSIFIED
    • thewire.inUNCLASSIFIED
    • tribuneindia.comUNCLASSIFIED
    identical copy

References

  • asiafoodjournal.comZeus Hygia’s Metaberine® clinical study published, demonstrating metabolic health benefits at just 200 mg dailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • business-standard.comZeus Hygia's Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • theprint.inZeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • thewire.inZeus Hygia’s Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09
  • tribuneindia.comZeus Hygias Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg DailyScreenshot as publishedOriginalcaptured 2026-08-17T18:29:09

Carried by multiple outlets

  • Zeus Hygia Lifesciences announced publication of a clinical study evaluating Metaberine®, a bio-optimised berberine formulation developed using proprietary BioSOLVE® Technologybusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study was published in the International Journal of Clinical Trialsbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study was a randomized, double-blind, placebo-controlled crossover trialbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • The study evaluated 36 healthy adults with fasting glucose levels of 100-125 mg/dLbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • Participants received Metaberine® 200 mg or placebo once daily for 14 days, followed by a seven-day washout periodbusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • Fasting glucose decreased by 9.08 mg/dL with Metaberine® compared with 1.36 mg/dL with placebobusiness-standard.com, theprint.in, thewire.in, tribuneindia.com
  • and 4 more, not shown